RHEUM || Rheumatoid Arthritis | European Federation of Internal Medicine

RA clinical remission possible with half etanercept dose

Posted on: 18/01/2015 - 16:30

Maintaining clinical remission with half-dose etanercept is possible for many rheumatoid arthritis patients, according to a single-center, prospective cohort study. Over 80% of rheumatoid arthritis...

Field of Interest: Rheumatology

Type: News Item

Number, not level, of positive antibodies predicts mortality in early RA

Posted on: 22/12/2014 - 13:27

Seropositivity for both rheumatoid factor and anti-citrullinated protein antibody was associated with increased mortality, compared with single positivity or seronegativity in patients with early...

Field of Interest: Rheumatology

Type: News Item

Tapering TNFi’s safe and much cheaper in RA

Posted on: 01/12/2014 - 21:47

BOSTON – Tapering but perhaps not completely stopping tumor necrosis factor inhibitors can result in good control of rheumatoid arthritis with considerable cost savings, according to investigators in...

Field of Interest: Rheumatology

Type: News Item

Nonsteroidal ‘DAGR’ looks sharp against RA

Posted on: 26/11/2014 - 16:06

BOSTON – A nonsteroidal investigational drug that acts on the glucocorticoid receptor was superior to placebo and noninferior to higher-dose prednisone in adults with rheumatoid arthritis,...

Field of Interest: Rheumatology

Type: News Item

VIDEO: DAGR may prove to be safer alternative to glucocorticoids

Posted on: 24/11/2014 - 22:19

BOSTON– In the search for safer alternatives to glucocorticoid therapy, DAGR (PF-0417327) may prove to be a contender. The investigational drug is a selective, high-affinity, dissociated agonist of...

Field of Interest: Rheumatology

Type: News Item

VIDEO: Lower heart failure risk seen in users of tumor necrosis factor inhibitors

Posted on: 18/11/2014 - 15:28

BOSTON – Rheumatoid arthritis patients taking tumor necrosis factor inhibitors ran a lower risk of developing congestive heart failure than did those on nonbiologic disease-modifying antirheumatic...

Field of Interest: Rheumatology

Type: News Item

VIDEO: Herpes zoster vaccination: Is it safe for rheumatology patients over age 30 on biologics?

Posted on: 18/11/2014 - 15:02

BOSTON– The herpes zoster vaccine may be safe to give to patients who are taking biologic therapies and have quiescent rheumatologic disorders, based on preliminary data from two studies presented at...

Field of Interest: Rheumatology

Type: News Item

RA draft guidelines: Treat to target

Posted on: 17/11/2014 - 18:35

BOSTON – Treat to target in both early and established rheumatoid arthritis, recommended the authors of American College of Rheumatology draft guidelines on the management of RA. The new ACR...

Field of Interest: Rheumatology

Type: News Item

Novel program improves RA care, cuts costs

Posted on: 17/11/2014 - 15:38

BOSTON– A bundle of eight measures was effective in improving the quality of rheumatoid arthritis care while reducing costs, Dr. Eric D. Newman reported at the annual meeting of the American College...

Field of Interest: Rheumatology

Type: News Item

Children born to mothers with RA more likely to be born early

Posted on: 13/11/2014 - 05:05

Children born to mothers with rheumatoid arthritis are more likely to be born prematurely and have a lower birth weight than are those born to mothers without the condition, according to a Danish...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

Latest Newsletters